HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Peng, Feng ^a   Xiao, Xinqiang ^a   Jiang, Yongfang ^a   Luo, Kaizhong ^a   Tian, Yi ^a   Peng, Milin ^a   Zhang, Min ^a   Xu, Yun ^a   Gong, Guozhong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLD2 PROTEIN; HEPATITIS B VIRUS X PROTEIN; MICRORNA 122; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; MICRORNA; MIRN122 MICRORNA, HUMAN; PAPD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GLD2 GENE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL LINE; GENETICS; LIVER CELL; METABOLISM; PHYSIOLOGY; VIROLOGY;

CELL LINE; DOWN-REGULATION; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MICRORNAS; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; TRANS-ACTIVATORS;

EID: 84899833942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092998     Document Type: Article

References (30)

1. Chang J, Nicolas E, Marks D, Sander C, Lerro A, et al. (2004) miR-122,a Mammalian liver-specific microRNA,is Processed from hcr mRNA and May Downregulate the High Affinity Cationic Amino Acid Transporter CAT-1. RNA Biol 1: 106-113.
2. Hu J, Xu Y, Hao J, Wang S, Li C, et al. (2012) MiR-122 in hepatic function and liver diseases. Protein Cell 3: 364-371. doi:10.1007/s13238-012- 2036-3.
3. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98.
4. Wen J, Friedman JR (2012) miR-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Invest 122: 2773-2776.
5. Hsu S, Wang B, Kota J, Yu J, Costinean S, et al. (2012) Essential metabolic, anti-inflammatory, and anti-tumorignic functions of miR-122 in liver. J Clin Invest 122: 2871-2883.
6. Lin CJF, Gong HY, Tseng HC, Wang WL, Wu JL (2008) miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 375: 315-320.
7. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, et al. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099. (Pubitemid 47037488)
8. Bai S, Nasser MW, Wang B, Hsu S-H, Datta J, et al. (2009) MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284: 32015-32027.
9. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, et al. (2011) Downregulation of miR-122 in the Rodent and Human Hepatocellular Carcinomas. J Cell Biochem 99: 671-678. doi:10.1002/jcb.20982.Downregulation. (Pubitemid 44521987)
10. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28: 3526-3536.
11. Tsai WC, Hsu PWC, Lai TC, Chau GY, Lin CW, et al. (2009) MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49: 1571-1582.
12. Ma L, Liu J, Shen J, Liu L, Wu J, et al. (2010) Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther 9: 554-561.
13. Chang J, Guo JT, Jiang D, Guo H, Taylor JM, et al. (2008) Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol 82: 8215-8223.
14. Janssen HL a, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, et al. (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368: 1685-1694.
15. Wang S, Qiu L, Yan X, Jin W, Wang Y, et al. (2012) Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Hepatology 55: 730-741.
16. Waidmann O, Bihrer V, Pleli T, Farnik H, Berger a, et al. (2012) Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat 19: e58-65.
17. Li C, Wang Y, Wang S, Wu B, Hao J, et al. (2013) Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol 87: 2193-2205.
18. Song K, Han C, Zhang J, Lu D, Dash S (2013) Epigenetic regulation of miR-122 by PPARc and hepatitis B virus X protein in hepatocellular carcinoma cells. Hepatology 58: 1681-1692.
19. Kwak JE, Wang L, Ballantyne S, Kimble J, Wickens M (2004) Mammalian GLD-2 homologs are poly(A) polymerases. Proc Natl Acad Sci U S A 101: 4407-4412. (Pubitemid 38437425)
20. Glahder J, Norrild B (2011) Involvement of hGLD-2 in cytoplasmic polyadenylation of human p53 mRNA. APMIS 199: 769-775.
21. Burns DM, D'Ambrogio A, Nottrott S, Richter JD (2011) CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation. Nature 473: 105-108.
22. D'Ambrogio A, Gu W, Udagawa T, Mello CC, Richter JD (2012) Specific miRNA stabilization by Gld2-catalyzed monoadenylation. Cell Rep 2: 1537-1545.
23. Katoh T, Sakaguchi Y, Miyauchi K, Suzuki T, Kashiwabara SI, et al. (2009) Selective stabilization of mammalian microRNAs by 39 adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev 23: 433-438.
24. Li ZY, Xi Y, Zhu WN, Zeng C, Zhang ZQ, et al. (2011) Positive regulation of hepatic miR-122 expression by HNF4a. J Hepatol 55: 602-611.
25. Bouchard MJ, Schneider RJ, Bouchard MJ, Schneider RJ (2004) The Enigmatic X Gene of Hepatitis B Virus. J Virol 78: 12725-12734. (Pubitemid 39507781)
26. JM, Newman M, Parker JS, Morin Kensicki EM, Wright T, et al. (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207.
27. Murakami S (1999) Hepatitis B virus X protein: structure, function and biology. Intervirology 42: 81-99.
28. Maeda Y, Hwang Verslues WW, Wei G, Fukazawa T, Durbin ML, et al. (2006) Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene. Biochem J 400: 303-313. (Pubitemid 44852043)
29. Müller BM, Wilder S, Bannasch D, Israeli D, Lehlbach K, et al. (1998) p53 Activates the CD95(APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs. J Exp Med 188: 2033-2045. (Pubitemid 28562520)
30. Ren M, Qin D, Li K, Qu J, Wang L, et al. (2012) Correlation between hepatitis B virus protein and microRNA processor Drosha in cells expressing HBV. Antiviral Res 94: 225-231.